Search Results - A. S. Kolbin
- Showing 1 - 20 results of 91
- Go to Next Page
-
1
-
2
-
3
-
4
PHARMACOECONOMICAL EVALUATION OF INVASIVE CANDIDOSIS PREVENTION IN THE NEONATES WITH VERY LOW BODY MASS by A.S. Kolbin
Published 2006-02-01
Article -
5
-
6
Why do we need "Real-World Data & Evidence", the new scientific electronic journal? by A. S. Kolbin
Published 2021-08-01
Article -
7
-
8
-
9
RISK FACTORS FOR DEVELOPMENT OF DISSEMINATED FORMS OF INTRUSIVE CANDIDIASIS AMONG CHILDREN SUFFERING FROM BURNS by A.S. Kolbin
Published 2006-12-01
Article -
10
-
11
-
12
ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY by T. L. Galankin, A. S. Kolbin
Published 2015-03-01
Article -
13
International experience in drug assessment for rare diseases: flexibility of approaches by K. S. Radaeva, A. S. Kolbin
Published 2024-09-01
Article -
14
ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT by A. A. Toporov, A. S. Kolbin
Published 2018-02-01
Article -
15
Using indirect comparisons in pharmacoeconomic examination by Yu. E. Balykina, A. S. Kolbin
Published 2015-03-01
Article -
16
Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers by E. V. Radchenko, A. S. Kolbin
Published 2019-07-01
Article -
17
Prospects for the use of allosteric drugs in real-world clinical practice by I. R. Svechkareva, A. S. Kolbin
Published 2023-12-01
Article -
18
CLINICAL TRIAL RESULS AND REAL WORLD MEDICAL EVIDENCE GAP by A. V. Philippova, A. S. Kolbin
Published 2018-03-01
Article -
19
What is the role of antineoplastic drug safety in reimbursement decision making? by A. S. Kolbin, A. A. Kurylev
Published 2018-11-01
Article -
20